Hideaki Kihara Selected Research

N- (2- (4- (5H- dibenzo(a,d)cyclohepten- 5- yliden)piperidino)ethyl)- 1- formyl- 4- piperidinecarboxamide (AT 1015)

3/2004

AT-1015, a novel serotonin2A receptor antagonist, improves resaturation of exercised ischemic muscle in hypercholesterolemic rabbits.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hideaki Kihara Research Topics

Disease

1	Constipation 10/2023
1	Sleep Wake Disorders 10/2023
1	Hypercholesterolemia 03/2004
1	Ischemia 03/2004

Drug/Important Bio-Agent (IBA)

1	AcidsIBA 10/2023
1	Oxygen (Dioxygen)IBA 03/2004
1	N- (2- (4- (5H- dibenzo(a,d)cyclohepten- 5- yliden)piperidino)ethyl)- 1- formyl- 4- piperidinecarboxamide (AT 1015)IBA 03/2004
1	5-HT2A Serotonin Receptor (5 HT2A Receptor)IBA 03/2004

Therapy/Procedure

1	Ligation 03/2004